Bexagliflozin is an organic compound used as a pharmaceutical raw material. It functions as a sodium-glucose cotransporter 2 (SGLT2) inhibitor and is employed in the manufacture of medications for glycemic control in type 2 diabetes.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1118567-05-7
Dapagliflozin Impurity D
reference standard for impurity testing
Dapagliflozin
active pharmaceutical ingredient
Dapagliflozin propanediol
sodium-glucose co-transporter 2 inhibitor
Empagliflozin
sodium-glucose cotransporter 2 inhibitor
Arginine Hydrochloride
active pharmaceutical ingredient
Tetradecyltrimethylammonium bromide
disinfectant and biocide active ingredient
5-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl]oxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3-carboxylic acid
pharmaceutical impurity reference standard
Ketiapin
active pharmaceutical ingredient
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(2-cyclopropyloxyethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
BTCRKOKVYTVOLU-SJSRKZJXSA-N
C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl